As per attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ms. Sathya Venkatachalam (DIN: 06970735) has resigned as Independent Director of Norris Medicines Ltd with effect from December 12, 2025, citing personal reasons. She also stepped down from all Board Committee memberships, including her role as Chairperson of the Audit Committee. She was the only Independent Director on the Board of this listed entity, and she confirmed there are no other material reasons for her resignation. The resignation letter and required disclosures under SEBI LODR Regulations have been submitted to BSE.
With her departure, the company loses its sole Independent Director and Audit Committee Chairperson, which may raise governance concerns and compliance risks around board composition and audit oversight. Investors should watch for a timely appointment of a replacement Independent Director to restore regulatory compliance.